相关实验视频

Updated: Sep 19, 2025

Author Spotlight: Using Motor Imagery Brain-Computer Interface to Improve Motor and Cognitive Function in Stroke Patients

Author Spotlight: Using Motor Imagery Brain-Computer Interface to Improve Motor and Cognitive Function in Stroke Patients

Published on: September 1, 2023

[在慢性脑性缺血患者中使用雷姆宾来纠正认知状态的经验]

N G Brash¹, N V Simonova², M I Arkhipova¹

¹Amur State Medical Academy, Blagoveshchensk, Russia.

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

|June 3, 2025

概括

在患有慢性脑缺血症 (CCI) 的患者中,Reamberin改善了认知功能. 这种药物增强了记忆,定向和适应能力,表明其潜在的治疗价值.

科学领域:

神经学神经学
药理学药理学是指药理学的学科.

背景情况:

慢性脑缺血 (CCI) 与显著的认知障碍有关.
对CCI和相关认知障碍需要有效的治疗策略.

研究的目的:

评估Reamberin作为诊断为患有慢性脑缺血症 (CCI) 和认知障碍的患者综合治疗的一部分的疗效.

主要方法:

一项随机对照试验,涉及35名CCI患者.
主要组 (n=16) 接受标准治疗加上静脉注射Reamberin (1.5%溶液,每天400毫升,持续10天).
对照组 (n=19) 仅接受标准治疗. 认知状态被评估.

主要成果:

在第11天 (p<0.05) 服用Reamberin导致MoCA测试得分 (+17%),延迟生殖 (+41%) 和导向 (+13%) 显著改善.
与对照组相比,接受Reamberin的患者在适应和精神稳定方面呈现了统计学上显著的积极变化 (p<0.05).
在Reamberin组中观察到增强的听觉短期和长期记忆功能.

结论:

雷安布林显示出作为一种有效的药物,在治疗与慢性脑缺血相关的认知缺陷方面具有潜力.
需要进一步的研究,以充分阐明Reamberin在CCI患者的治疗作用.

关键词:

在Reamberin中使用Reamberin.抗氧化剂状态抗氧化剂状态慢性大脑缺血症慢性大脑缺血症认知状态认知状态

更多相关视频

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure

Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure

Published on: May 31, 2024

相关概念视频

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.